{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:55:49Z","timestamp":1793382949092,"version":"4.5.0"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"HTRS\/Novo Nordisk Clinical Fellowship in Hemophilia and Rare Bleeding Disorders"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.blre.2019.100638","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T19:17:36Z","timestamp":1573067856000},"page":"100638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Thrombocytopenia in pregnancy: Diagnosis and approach to management"],"prefix":"10.1016","volume":"40","author":[{"given":"Allyson M.","family":"Pishko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa D.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas B.","family":"Cines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2019.100638_bb0005","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1182\/blood-2017-05-781971","article-title":"Thrombocytopenia in pregnancy","volume":"130","author":"Cines","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1802897","article-title":"Platelet counts during pregnancy","volume":"379","author":"Reese","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2019.100638_bb0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/blood-2012-08-448944","article-title":"How I treat thrombocytopenia in pregnancy","volume":"121","author":"Gernsheimer","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0020","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.ultrasmedbio.2006.06.017","article-title":"Normal sonographic values of maternal spleen size throughout pregnancy","volume":"32","author":"Maymon","year":"2006","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.blre.2019.100638_bb0025","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1097\/AOG.0000000000001641","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2019.100638_bb0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejogrb.2018.10.026","article-title":"Clinical characteristics, neonatal risk and recurrence rate of gestational thrombocytopenia with platelet count <100 x 10(9)\/L","volume":"231","author":"Rottenstreich","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.blre.2019.100638_bb0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/jog.12496","article-title":"Clinical features of gestational thrombocytopenia difficult to differentiate from immune thrombocytopenia diagnosed during pregnancy","volume":"41","author":"Kasai","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.blre.2019.100638_bb0040","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy","volume":"122","author":"American College of Obstetricians and Gynecologists","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2019.100638_bb0045","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/AOG.0b013e3181fe02ec","article-title":"Association of anticardiolipin antibodies with preeclampsia: a systematic review and meta-analysis","volume":"116","author":"do Prado","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2019.100638_bb0050","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/AOG.0000000000002980","article-title":"Terminal complement activation in preeclampsia","volume":"132","author":"Burwick","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2019.100638_bb0055","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"Mol","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2019.100638_bb0060","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2215\/CJN.12081115","article-title":"Preeclampsia: updates in pathogenesis, definitions, and guidelines","volume":"11","author":"Phipps","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.blre.2019.100638_bb0065","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood-2016-03-705434","article-title":"Maternal extracellular vesicles and platelets promote preeclampsia via inflammasome activation in trophoblasts","volume":"128","author":"Kohli","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0070","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.2017.3439","article-title":"Screening for preeclampsia: US preventive services task Force recommendation StatementUSPSTF recommendation: screening for PreeclampsiaUSPSTF recommendation: screening for preeclampsia","volume":"317","author":"Force","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2019.100638_bb0075","first-page":"e1","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2019.100638_bb0080","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1136\/heartjnl-2011-300949","article-title":"Hypertension in pregnancy: the NICE guidelines","volume":"97","author":"Redman","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.blre.2019.100638_bb0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.blre.2019.100638_bb0090","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/14767058.2016.1189897","article-title":"Disseminated intravascular coagulation in the HELLP syndrome: how much do we really know?","volume":"30","author":"Haram","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.blre.2019.100638_bb0095","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/HYPERTENSIONAHA.111.00226","article-title":"Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension","volume":"61","author":"Bauer","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.blre.2019.100638_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.12.038","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","volume":"214","author":"Costantine","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.blre.2019.100638_bb0105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12884-017-1594-z","article-title":"STRIDER (sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials","volume":"17","author":"Pels","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.blre.2019.100638_bb0110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","article-title":"Pre-eclampsia: pathogenesis, novel diagnostics and therapies","volume":"15","author":"Phipps","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.blre.2019.100638_bb0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa011379","article-title":"The interval between pregnancies and the risk of preeclampsia","volume":"346","author":"Skjaerven","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2019.100638_bb0120","doi-asserted-by":"crossref","first-page":"b2255","DOI":"10.1136\/bmj.b2255","article-title":"Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study","volume":"338","author":"Hernandez-Diaz","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.blre.2019.100638_bb0125","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"743: low-dose aspirin use during pregnancy","volume":"132","author":"Committee Opinion No","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2019.100638_bb0130","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2019.100638_bb0135","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2019.100638_bb0140","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/S0140-6736(16)31139-4","article-title":"Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials","volume":"388","author":"Rodger","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2019.100638_bb0145","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/jth.13976","article-title":"Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH","volume":"16","author":"Devreese","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2019.100638_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8249264","article-title":"The effects of vitamin D supplement on prevention of recurrence of preeclampsia in pregnant women with a history of preeclampsia","volume":"2017","author":"Behjat Sasan","year":"2017","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.blre.2019.100638_bb0155","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12884-017-1408-3","article-title":"The role of vitamin D in pre-eclampsia: a systematic review","volume":"17","author":"Purswani","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"issue":"6","key":"10.1016\/j.blre.2019.100638_bb0160","article-title":"Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems","volume":"24","author":"Hofmeyr","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.blre.2019.100638_bb0165","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/AOG.0000000000000140","article-title":"Risk factors, management, and outcomes of hemolysis, elevated liver enzymes, and low platelets syndrome and elevated liver enzymes, low platelets syndrome","volume":"123","author":"Fitzpatrick","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2019.100638_bb0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejogrb.2012.09.026","article-title":"Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review","volume":"166","author":"Abildgaard","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.blre.2019.100638_bb0175","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1055\/s-2002-36693","article-title":"Gestational thrombocytopenia and pregnancy-induced antithrombin deficiency: progenitors to the development of the HELLP syndrome and acute fatty liver of pregnancy","volume":"28","author":"Minakami","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.blre.2019.100638_bb0180","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99128","article-title":"Germline mutations in the alternative pathway of complement predispose to HELLP syndrome","volume":"3","author":"Vaught","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.blre.2019.100638_bb0185","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1182\/asheducation-2018.1.371","article-title":"Complement-driven anemia: more than just paroxysmal nocturnal hemoglobinuria","volume":"2018","author":"Merrill","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2019.100638_bb0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2393-9-8","article-title":"The HELLP syndrome: clinical issues and management. A review","volume":"9","author":"Haram","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.blre.2019.100638_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.01.009","article-title":"Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis","volume":"212","author":"van Oostwaard","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.blre.2019.100638_bb0200","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ajg.2017.54","article-title":"Acute fatty liver disease of pregnancy: updates in pathogenesis, diagnosis, and management","volume":"112","author":"Liu","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.blre.2019.100638_bb0205","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1001\/jama.288.17.2163","article-title":"Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease","volume":"288","author":"Yang","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2019.100638_bb0210","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.51.6.876","article-title":"Prospective study of liver dysfunction in pregnancy in Southwest Wales","volume":"51","author":"Ch'ng","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.blre.2019.100638_bb0215","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/jog.12282","article-title":"Differentiation of acute fatty liver of pregnancy from syndrome of hemolysis, elevated liver enzymes and low platelet counts","volume":"40","author":"Minakami","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.blre.2019.100638_bb0220","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00404-015-3941-5","article-title":"Prenatal predictors in postpartum recovery for acute fatty liver of pregnancy: experiences at a tertiary referral center","volume":"293","author":"Meng","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.blre.2019.100638_bb0225","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: pathogenic and clinical diversity","volume":"113","author":"Cines","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0230","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood-2009-04-215368","article-title":"The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases","volume":"114","author":"Michel","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0235","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2141.1996.d01-1702.x","article-title":"Circulating thrombopoietin level in chronic immune thrombocytopenic purpura","volume":"93","author":"Kosugi","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2019.100638_bb0240","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/ajh.23562","article-title":"Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists","volume":"88","author":"Makar","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2019.100638_bb0245","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.18632\/oncotarget.7106","article-title":"Thrombopoietin: a potential diagnostic indicator of immune thrombocytopenia in pregnancy","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.blre.2019.100638_bb0250","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/bjh.12976","article-title":"Effect of pregnancy on the course of immune thrombocytopenia: a retrospective study of 118 pregnancies in 82 women","volume":"166","author":"Loustau","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2019.100638_bb0255","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood-2016-04-710285","article-title":"Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy","volume":"128","author":"Sun","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0260","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1080\/14767058.2017.1344636","article-title":"Improved pregnancy outcome following earlier splenectomy in women with immune thrombocytopenia: a 5-year observational study","volume":"31","author":"Rezk","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"10.1016\/j.blre.2019.100638_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007722","article-title":"Medical treatments for idiopathic thrombocytopenic purpura during pregnancy","volume":"2009","author":"Marti-Carvajal","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.blre.2019.100638_bb0270","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies","volume":"62","author":"Park-Wyllie","year":"2000","journal-title":"Teratology"},{"key":"10.1016\/j.blre.2019.100638_bb0275","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1515\/JPM.2006.053","article-title":"Gestational diabetes mellitus in patients receiving long-term corticosteroid therapy during pregnancy","volume":"34","author":"Yildirim","year":"2006","journal-title":"J Perinat Med"},{"key":"10.1016\/j.blre.2019.100638_bb0280","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1182\/blood-2016-03-603365","article-title":"How I treat refractory immune thrombocytopenia","volume":"128","author":"Cuker","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0285","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1182\/blood-2017-09-742353","article-title":"Splenectomy for immune thrombocytopenia: down but not out","volume":"131","author":"Chaturvedi","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0290","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0295","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"Gotestam Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.blre.2019.100638_bb0300","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.cgh.2018.11.055","article-title":"Outcomes of pregnancy in recipients of liver transplants","volume":"17","author":"Kamarajah","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.blre.2019.100638_bb0305","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1365-2141.2003.04567.x","article-title":"Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy","volume":"123","author":"Michel","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2019.100638_bb0310","series-title":"WinRho SDF Rho(D) Immune Globulin (Human)","author":"Saol Therapeutics","year":"2019"},{"key":"10.1016\/j.blre.2019.100638_bb0315","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood-2017-04-748707","article-title":"Safety and efficacy of long-term treatment of chronic\/persistent ITP with eltrombopag: final results of the EXTEND study","volume":"130","author":"Wong","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0320","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3324\/haematol.2016.161968","article-title":"Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia","volume":"102","author":"Cines","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2019.100638_bb0325","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12185-017-2383-1","article-title":"A low birth weight infant with no malformations delivered by a primary immune thrombocytopenia patient treated with eltrombopag","volume":"108","author":"Suzuki","year":"2018","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2019.100638_bb0330","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jogoh.2018.06.010","article-title":"Severe immune thrombocytopenia in pregnancy treated with Eltrombopag - a case report","volume":"47","author":"Ferreira","year":"2018","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.blre.2019.100638_bb0335","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1182\/blood-2017-01-761262","article-title":"A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy","volume":"130","author":"Kong","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0340","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1182\/blood-2002-10-3317","article-title":"A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura","volume":"102","author":"Webert","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0345","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF02982137","article-title":"Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates","volume":"75","author":"Fujimura","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2019.100638_bb0350","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/MBC.0000000000000758","article-title":"Neonates born to mothers with immune thrombocytopenia: 11 years experience of a single academic center","volume":"29","author":"Karakurt","year":"2018","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.blre.2019.100638_bb0355","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0002-9378(97)70454-X","article-title":"Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia","volume":"177","author":"Payne","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.blre.2019.100638_bb0360","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajh.22178","article-title":"Reliable predictors of neonatal immune thrombocytopenia in pregnant women with idiopathic thrombocytopenic purpura","volume":"87","author":"Koyama","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2019.100638_bb0365","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0029-7844(97)00349-9","article-title":"Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpura","volume":"90","author":"Christiaens","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2019.100638_bb0370","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5045\/br.2014.49.4.259","article-title":"Can we predict neonatal thrombocytopenia in offspring of women with idiopathic thrombocytopenic purpura?","volume":"49","author":"Hachisuga","year":"2014","journal-title":"Blood Res"},{"key":"10.1016\/j.blre.2019.100638_bb0375","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJM198204083061402","article-title":"Immune thrombocytopenic purpura and pregnancy","volume":"306","author":"Cines","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2019.100638_bb0380","first-page":"1","article-title":"Circulating antiplatelet antibodies in pregnant women with immune thrombocytopenic purpura as predictors of thrombocytopenia in the newborns","author":"Khaspekova","year":"2019","journal-title":"Platelets"},{"key":"10.1016\/j.blre.2019.100638_bb0385","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2009.11.022","article-title":"Evans' syndrome in pregnancy: a systematic literature review and two new cases","volume":"149","author":"Lefkou","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.blre.2019.100638_bb0390","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2010-03-259325","article-title":"How I treat autoimmune hemolytic anemias in adults","volume":"116","author":"Lechner","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0395","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/asheducation-2017.1.385","article-title":"Hereditary thrombocytopenias: a growing list of disorders","volume":"2017","author":"Noris","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2019.100638_bb0400","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2141.2006.06343.x","article-title":"A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO","volume":"135","author":"Bolton-Maggs","year":"2006","journal-title":"Br J Haematol"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2019.100638_bb0405","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2516.2007.01607.x","article-title":"Desmopressin in inherited disorders of platelet function","volume":"14","author":"Coppola","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.100638_bb0410","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3324\/haematol.2014.105924","article-title":"Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia","volume":"99","author":"Noris","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2019.100638_bb0415","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1182\/asheducation-2016.1.232","article-title":"Congenital and acquired bleeding disorders in pregnancy","volume":"2016","author":"Gernsheimer","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2019.100638_bb0420","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood-2010-05-283507","article-title":"Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study","volume":"116","author":"Comellas-Kirkerup","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0425","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.blre.2019.100638_bb0430","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/ard.2006.061671","article-title":"Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases","volume":"66","author":"Gomez-Puerta","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.blre.2019.100638_bb0435","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.blre.2017.07.006","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"31","author":"Chaturvedi","year":"2017","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2019.100638_bb0440","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","article-title":"Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)","volume":"87","author":"McNeil","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2019.100638_bb0445","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1191\/0961203303lu397oa","article-title":"Activation of complement mediates antiphospholipid antibody-induced pregnancy loss","volume":"12","author":"Salmon","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.blre.2019.100638_bb0450","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V82.9.2730.2730","article-title":"Detection of antitrophoblast antibodies in the sera of patients with anticardiolipin antibodies and fetal loss","volume":"82","author":"McCrae","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0455","first-page":"1290","article-title":"Management of the antiphospholipid syndrome","volume":"379","author":"Garcia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2019.100638_bb0460","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2019.100638_bb0465","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1445-5994.1990.tb01025.x","article-title":"Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population","volume":"20","author":"Shi","year":"1990","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.blre.2019.100638_bb0470","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/10245332.2018.1532649","article-title":"Relevance of antiphospholipid antibody profile in the clinical outcome of ITP: a single-centre study","volume":"24","author":"Frison","year":"2019","journal-title":"Hematology"},{"issue":"9","key":"10.1016\/j.blre.2019.100638_bb0475","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/imj.14269","article-title":"Characteristics, risk factors and management of venous thromboembolism in immune thrombocytopenia: a retrospective multicenter study","volume":"49","author":"Le Guenno","year":"2019","journal-title":"Intern Med J"},{"key":"10.1016\/j.blre.2019.100638_bb0480","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.blre.2019.100638_bb0485","article-title":"Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study","volume":"216","author":"Saccone","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.blre.2019.100638_bb0490","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1097\/01.AOG.0000423816.39542.0f","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2019.100638_bb0495","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2019.100638_bb0500","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.autrev.2018.05.012","article-title":"HIBISCUS: hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome","volume":"17","author":"Belizna","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.blre.2019.100638_bb0505","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1182\/blood-2014-08-551960","article-title":"How I treat type 2 variant forms of von Willebrand disease","volume":"125","author":"Tosetto","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112935","article-title":"Complex changes in von Willebrand factor-associated parameters are acquired during uncomplicated pregnancy","volume":"9","author":"Drury-Stewart","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.blre.2019.100638_bb0515","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2516.2011.02691.x","article-title":"Pregnancy in type 2B VWD: a case series","volume":"18","author":"Ranger","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.100638_bb0520","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1182\/blood-2017-06-742692","article-title":"How I treat type 2B von Willebrand disease","volume":"131","author":"Kruse-Jarres","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0525","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1182\/bloodadvances.2017005082","article-title":"Antifibrinolytic therapy for preventing VWD-related postpartum hemorrhage: indications and limitations","volume":"1","author":"Kouides","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2019.100638_bb0530","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S2352-3026(16)30018-7","article-title":"Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy","volume":"3","author":"Mariotte","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.blre.2019.100638_bb0535","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2014-02-553131","article-title":"Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes","volume":"124","author":"Scully","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0540","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1182\/asheducation-2013.1.292","article-title":"Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies","volume":"2013","author":"Crawley","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2019.100638_bb0545","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1160\/TH03-11-0683","article-title":"von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women","volume":"92","author":"Sanchez-Luceros","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2019.100638_bb0550","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/bjh.14045","article-title":"How we manage thrombotic microangiopathies in pregnancy","volume":"173","author":"Thomas","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2019.100638_bb0555","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1182\/blood-2010-07-271445","article-title":"How I treat patients with thrombotic thrombocytopenic purpura: 2010","volume":"116","author":"George","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0560","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"115","author":"Kremer Hovinga","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0565","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1182\/asheducation-2018.1.548","article-title":"TTP: long-term outcomes following recovery","volume":"2018","author":"George","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2019.100638_bb0570","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1182\/blood-2013-11-538900","article-title":"Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura","volume":"123","author":"Jiang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0575","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1055\/s-0036-1587683","article-title":"Thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome microangiopathy in pregnancy","volume":"42","author":"Scully","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.blre.2019.100638_bb0580","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1182\/blood-2012-02-408914","article-title":"Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura","volume":"119","author":"Moatti-Cohen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0585","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/ajh.24311","article-title":"Congenital thrombotic thrombocytopenic purpura related to a novel mutation in ADAMTS13 gene and management during pregnancy","volume":"91","author":"Epperla","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2019.100638_bb0590","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/blood-2016-11-709865","article-title":"HUS and atypical HUS","volume":"129","author":"Jokiranta","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100638_bb0595","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1681\/ASN.2016090995","article-title":"Maternal and fetal outcomes of pregnancies in women with atypical hemolytic uremic syndrome","volume":"29","author":"Gaggl","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.blre.2019.100638_bb0600","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.blre.2019.100638_bb0605","series-title":"Soliris (eculizumab). Package insert","year":"2007"},{"key":"10.1016\/j.blre.2019.100638_bb0610","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.transci.2014.08.027","article-title":"Innovative therapeutic approach: sequential treatment with plasma exchange and eculizumab in a pregnant woman affected by atypical hemolytic-uremic syndrome","volume":"51","author":"Mussoni","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.blre.2019.100638_bb0615","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40620-018-0517-z","article-title":"Eculizumab in pregnancy: a narrative overview","volume":"32","author":"Sarno","year":"2019","journal-title":"J Nephrol"},{"key":"10.1016\/j.blre.2019.100638_bb2000","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1505533","article-title":"Caplacizumab for acquired thrombotic thrombocytopenic purpura","volume":"374","author":"Peyvandi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2019.100638_bb2005","series-title":"(Caplacizumab-yhdp) [package insert on the Internet]","author":"Cablivi\u00ae","year":"2019"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X19301523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X19301523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T20:23:03Z","timestamp":1759436583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X19301523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":125,"alternative-id":["S0268960X19301523"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2019.100638","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombocytopenia in pregnancy: Diagnosis and approach to management","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2019.100638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100638"}}